Extension of Time to File SOU

PTO Form 1581 (Rev 9/2005)

OMB No. 0651-0054 (Exp. 09/30/2011)

---

PTO Form 1581 (Rev 9/2005)

OMB No. 0651-0054 (Exp. 09/30/2011)

SOU Extension Request
(15 U.S.C. Section 1051(d))

To the Commissioner for Trademarks:

MARK: SPERAZAN
SERIAL NUMBER: 76627252

The applicant, Merck & Co., Inc., having an address of One Merck Drive P.O. Box 100, Whitehouse Station, New Jersey United States 08889-0100, requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 12/20/2005.

For International Class 005:
Current identification: Pharmaceutical preparations for the treatment of addiction, urinary incontinence, diabetes, cardiovascular diseases and disorders, cerebrovascular diseases and disorders, anxiety, depression, insomnia, cognitive disorders, diseases and disorders of the central nervous system, cancer, obesity, inflammation and inflammatory diseases, respiratory diseases and disorders, musculoskeletal disorders, osteoporosis, menopausal symptoms and disorders, anti-infective preparations, anti-viral preparations, immunological preparations, analgesic preparations, ophthalmic preparations

This filing does NOTcover the following goods or services listed in either the application or Notice of Allowance or as subsequently modified for this specific class; these goods or services are either being permanently deleted or included in a separately filed Request to Divide: urinary incontinence, anxiety, depression, insomnia, gastrointestinal diseases and disorders, inflammation and inflammatory diseases, menopausal symptoms and disorders, ophthalmic preparations, antiemetic preparations

The applicant has a continued bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the following goods or services listed in the Notice of Allowance or as subsequently modified for this specific class: Pharmaceutical preparations for the treatment of addiction, diabetes, cardiovascular diseases and disorders, cerebrovascular diseases and disorders, cognitive disorders, diseases and disorders of the central nervous system, cancer, obesity, respiratory diseases and disorders, musculoskeletal disorders, osteoporosis, anti-infective preparations, antiviral preparations, immunological preparations, analgesic preparations.

This is the fifth extension request.   The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods and/or services covered by the extension request: product or service research development

The applicant hereby appoints Debra A. Shelinsky Greene and Kevin M. Dugan, Robert Peverada, Susan C. Mattson of  MERCK & CO., INC., One Merck Drive, P.O. Box 100, WHITEHOUSE STATION, New Jersey United States 08889-0100 to submit this Request for Extension of Time to File a Statement of Use on behalf of the applicant.

A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.


Declaration

The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /kmd/      Date Signed: 06/12/2008
Signatory's Name: Kevin M. Dugan
Signatory's Position: Attorney

Mailing Address:
   MERCK & CO., INC.
   
   PO BOX 100
   WHITEHOUSE STATION, New Jersey 08889-0100

Mailing Address:
   MERCK & CO., INC.
   
   One Merck Drive, P.O. Box 100
   WHITEHOUSE STATION, New Jersey 08889-0100

RAM Sale Number: 6069
RAM Accounting Date: 06/12/2008

Serial Number: 76627252
Internet Transmission Date: Thu Jun 12 09:57:37 EDT 2008
TEAS Stamp: USPTO/ESU-XXX.XX.XX.XXX-2008061209573798
6814-76627252-4003261a32ca26ef8c5e2ec947
3a1e66e41-DA-6069-20080612093442319483